Published in Hum Mutat on February 11, 2013
Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell (2014) 3.68
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment. Nature (2015) 2.21
Mutant p53 - Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival. Front Endocrinol (Lausanne) (2015) 0.86
The MDM2 285G-309G haplotype is associated with an earlier age of tumour onset in patients with Li-Fraumeni syndrome. Fam Cancer (2014) 0.78
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma. Genome Med (2016) 0.75
p53 gain-of-function mutations promote metastasis via ENTPD5 upregulation and enhanced N-glycoprotein folding. Mol Cell Oncol (2017) 0.75
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet (2005) 7.66
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature (2008) 5.32
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA (2011) 4.84
Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst (2007) 2.77
Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA (2005) 2.59
The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet (2005) 2.26
Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet (2006) 2.23
Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. Brain (2013) 2.02
2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol (2009) 1.97
Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis. Arthritis Res Ther (2006) 1.90
Ethics and observational studies in medical research: various rules in a common framework. Int J Epidemiol (2009) 1.85
Phenotype associated with APP duplication in five families. Brain (2006) 1.83
The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol (2009) 1.70
Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum Mutat (2002) 1.66
Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer. J Clin Oncol (2009) 1.62
Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions. Hum Mutat (2012) 1.61
TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. J Alzheimers Dis (2013) 1.57
Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet (2006) 1.50
Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations. Mod Pathol (2009) 1.48
MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res (2002) 1.41
Pyogenic Sacroiliitis in a 13-Month-Old Child: A Case Report and Literature Review. Medicine (Baltimore) (2015) 1.40
Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls. Mod Pathol (2011) 1.28
Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers. Eur J Hum Genet (2011) 1.21
Inactivation of the RRB1-Pescadillo pathway involved in ribosome biogenesis induces chromosomal instability. Oncogene (2004) 1.17
The intrafamilial variability of the 22q11.2 microduplication encompasses a spectrum from minor cognitive deficits to severe congenital anomalies. Am J Med Genet A (2006) 1.15
Estimating cancer risk in HNPCC by the GRL method. Eur J Hum Genet (2007) 1.13
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol (2010) 1.12
Thyroid developmental anomalies in first degree relatives of children with congenital hypothyroidism. J Clin Endocrinol Metab (2002) 1.12
Overexpression of B-type cyclins alters chromosomal segregation. Oncogene (2002) 1.11
Estimating cancer risks from a retrospective cohort of patients with MMR gene mutations. J Clin Oncol (2013) 1.06
Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors. Genes Chromosomes Cancer (2008) 1.05
Contribution of the BOP1 gene, located on 8q24, to colorectal tumorigenesis. Genes Chromosomes Cancer (2006) 1.04
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet (2012) 1.04
The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers. J Alzheimers Dis (2012) 1.03
Association study of the GAB2 gene with the risk of developing Alzheimer's disease. Neurobiol Dis (2008) 1.03
Molecular predictive factors for progression of high-grade preinvasive bronchial lesions. Am J Respir Crit Care Med (2007) 1.02
Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset. Genet Epidemiol (2004) 1.02
Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev (2005) 1.01
Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett (2002) 1.00
Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques. Hum Mutat (2006) 0.97
Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France. Pediatr Blood Cancer (2004) 0.97
Early onset brain tumor and lymphoma in MSH2-deficient children. Am J Hum Genet (2003) 0.96
Deciphering the colon cancer genes--report of the InSiGHT-Human Variome Project Workshop, UNESCO, Paris 2010. Hum Mutat (2011) 0.96
TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance? Eur J Hum Genet (2010) 0.94
Prognostic value of circulating mutant DNA in unresectable metastatic colorectal cancer. Ann Surg (2010) 0.94
Altered gene expression in acute systemic inflammation detected by complete coverage of the human liver transcriptome. Hepatology (2004) 0.93
Detection of a large genomic deletion in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet (2006) 0.93
A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease. Eur J Hum Genet (2011) 0.92
Overall mutational spectrum of SLC20A2, PDGFB and PDGFRB in idiopathic basal ganglia calcification. Neurogenetics (2014) 0.91
Neuropathological review of 138 cases genetically tested for X-linked hydrocephalus: evidence for closely related clinical entities of unknown molecular bases. Acta Neuropathol (2013) 0.91
Tumor necrosis factor (TNF)-alpha persistently activates nuclear factor-kappaB signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammation. Endocrinology (2008) 0.90
The inflammation-induced down-regulation of plasma Fetuin-A (alpha2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites. Nucleic Acids Res (2003) 0.89
Early-onset low-grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg). Am J Med Genet A (2006) 0.89
Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia. Arthritis Res Ther (2009) 0.88
Performance and cost efficiency of KRAS mutation testing for metastatic colorectal cancer in routine diagnosis: the MOKAECM study, a nationwide experience. PLoS One (2013) 0.86
Gene profiling predicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra). Rheumatology (Oxford) (2010) 0.86
Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition. J Hepatol (2005) 0.86
Sex ratio among the offspring of BRCA mutation carriers. JAMA (2004) 0.86
The 5' region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences. Hum Mutat (2005) 0.86
Clinical and biochemical heterogeneity associated with fumarase deficiency. Hum Mutat (2011) 0.86
Is the saitohin gene involved in neurodegenerative diseases? Ann Neurol (2002) 0.85
Frontotemporal dementia phenotype associated with MAPT gene duplication. J Alzheimers Dis (2010) 0.85
Comparative gene expression profiling of olfactory ensheathing cells from olfactory bulb and olfactory mucosa. Glia (2010) 0.85
Inhibition of tumor growth and metastatic spreading by overexpression of inter-alpha-trypsin inhibitor family chains. Int J Cancer (2002) 0.85
A multiplex technology platform for the rapid analysis of clinically actionable genetic alterations and validation for BRAF p.V600E detection in 1549 cytologic and histologic specimens. Arch Pathol Lab Med (2013) 0.84
A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24. Brain (2004) 0.84
Isolation, characterization, and genetic profiling of subpopulations of olfactory ensheathing cells from the olfactory bulb. Glia (2011) 0.83
An information-theoretic analysis of genetics, gender and age in cancer patients. PLoS One (2008) 0.83
Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients. Int J Cancer (2006) 0.83
Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer. Int J Cancer (2002) 0.82
Pitfalls in the use of DGV for CNV interpretation. Am J Med Genet A (2011) 0.82
Gradual reduction of BUBR1 protein levels results in premature sister-chromatid separation then in aneuploidy. Hum Genet (2008) 0.81
Metastasis models: the green fluorescent revolution? Carcinogenesis (2004) 0.81
On the use of sibling recurrence risks to select environmental factors liable to interact with genetic risk factors. Eur J Hum Genet (2010) 0.81
Amyloid-β protein precursor gene expression in alzheimer's disease and other conditions. J Alzheimers Dis (2012) 0.81
Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumours. Eur J Hum Genet (2013) 0.80
Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation. Eur J Hum Genet (2005) 0.80
Type I hyperprolinemia: genotype/phenotype correlations. Hum Mutat (2010) 0.80
Detection of APC gene deletions using quantitative multiplex PCR of short fluorescent fragments. Clin Chem (2008) 0.80
Partial deletion of the MAPT gene: a novel mechanism of FTDP-17. Hum Mutat (2009) 0.80
[A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predisposition]. Bull Cancer (2011) 0.80
A simple method for the routine detection of somatic quantitative genetic alterations in colorectal cancer. Gastroenterology (2006) 0.79
Parent-of-origin effect in transthyretin related amyloid polyneuropathy. Amyloid (2009) 0.79
No replication of the association between the Nicastrin gene and familial early-onset Alzheimer's disease. Neurosci Lett (2003) 0.79
Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer. Eur J Hum Genet (2007) 0.79
Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. Am J Med Genet B Neuropsychiatr Genet (2003) 0.79
Myoclonus dystonia plus syndrome due to a novel 7q21 microdeletion. Am J Med Genet A (2010) 0.79
The MDM2 285G-309G haplotype is associated with an earlier age of tumour onset in patients with Li-Fraumeni syndrome. Fam Cancer (2014) 0.78
Genetic variations of the A13/A14 repeat located within the EGFR 3' untranslated region have no oncogenic effect in patients with colorectal cancer. BMC Cancer (2013) 0.78
[Juvenile polyposis coli. The usefulness of a genetic study and the role of surgical treatment]. Gastroenterol Clin Biol (2002) 0.78